DE SANCTIS, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.507
EU - Europa 3.374
AS - Asia 2.199
SA - Sud America 331
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 87
OC - Oceania 12
Totale 9.674
Nazione #
US - Stati Uniti d'America 3.405
RU - Federazione Russa 1.280
SG - Singapore 835
IT - Italia 679
CN - Cina 566
GB - Regno Unito 391
DE - Germania 266
VN - Vietnam 256
BR - Brasile 252
HK - Hong Kong 222
FI - Finlandia 152
IE - Irlanda 129
FR - Francia 127
SE - Svezia 121
KR - Corea 69
NL - Olanda 65
IN - India 48
CA - Canada 45
ID - Indonesia 41
BD - Bangladesh 34
UA - Ucraina 33
TR - Turchia 28
AT - Austria 27
AR - Argentina 26
JP - Giappone 25
MX - Messico 24
ZA - Sudafrica 22
BE - Belgio 19
PL - Polonia 18
ES - Italia 16
TG - Togo 16
IQ - Iraq 15
CO - Colombia 14
NG - Nigeria 13
SA - Arabia Saudita 12
EC - Ecuador 11
BJ - Benin 10
JM - Giamaica 10
PK - Pakistan 10
PY - Paraguay 9
VE - Venezuela 9
AU - Australia 8
CZ - Repubblica Ceca 8
CR - Costa Rica 6
KE - Kenya 6
LT - Lituania 6
CL - Cile 5
TN - Tunisia 5
EG - Egitto 4
HR - Croazia 4
IL - Israele 4
MA - Marocco 4
NI - Nicaragua 4
PH - Filippine 4
PT - Portogallo 4
RS - Serbia 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
HN - Honduras 3
NZ - Nuova Zelanda 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
Totale 9.499
Città #
Ashburn 514
Moscow 482
Singapore 422
San Jose 392
Verona 351
Southend 288
Chandler 247
Dallas 238
Hong Kong 214
Council Bluffs 170
Munich 168
Beijing 124
Dublin 123
New York 113
Helsinki 84
Jacksonville 84
The Dalles 79
Redmond 74
Los Angeles 73
Ho Chi Minh City 62
Santa Clara 53
Houston 50
Woodbridge 48
Hanoi 43
Dong Ket 37
Jakarta 37
Wilmington 37
Lawrence 36
Princeton 36
Ann Arbor 33
Jinan 32
São Paulo 30
Buffalo 29
London 27
Orem 26
Redondo Beach 26
Turku 26
Milan 25
Tokyo 24
Columbus 22
Nanjing 22
Shenyang 22
Denver 21
Lappeenranta 21
Atlanta 20
Chicago 20
Phoenix 20
Montreal 19
Amsterdam 18
Brussels 18
Washington 18
Frankfurt am Main 17
Brooklyn 16
Johannesburg 16
Lomé 16
Rome 16
Hebei 15
Redwood City 15
Sindelfingen 15
Warsaw 15
Toronto 14
Zhengzhou 14
Guangzhou 13
Hangzhou 13
Vienna 13
Abuja 12
Haikou 12
Nanchang 12
Seattle 12
Boston 11
Haiphong 11
Las Vegas 11
Manchester 11
McKinney 11
Poplar 11
Stockholm 11
Tianjin 11
Boydton 10
Chennai 10
Cotonou 10
Jiaxing 10
Mexico City 10
Nuremberg 10
Seoul 10
Belo Horizonte 9
New Delhi 8
Ningbo 8
Paris 8
Querétaro 8
San Francisco 8
St Louis 8
Taizhou 8
Boardman 7
Brasília 7
Falkenstein 7
Ankara 6
Baghdad 6
Barnet 6
Bogotá 6
Bologna 6
Totale 5.728
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 328
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 313
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 275
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 266
Deciphering the state of immune silence in fatal COVID-19 patients 252
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 236
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 231
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 228
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 221
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 218
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 214
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 211
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 206
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 204
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice 202
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 201
Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo 189
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 187
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 185
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 182
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 179
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 178
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer 173
The Endless Saga of Monocyte Diversity 172
Anti-telomerase T cells adoptive transfer 172
Local ablation disrupts immune evasion in pancreatic cancer 171
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 169
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis 165
A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma 162
The Engagement Between MDSCs and Metastases: Partners in Crime 159
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies 156
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 155
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature 149
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 142
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines 140
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 139
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 138
T-cell tracking using Cerenkov and radioluminescence imaging 136
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo 135
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 134
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 134
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 121
Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors 119
Monocytes in the Tumor Microenvironment 118
Overview of the optical properties of fluorescent nanoparticles for optical imaging 117
Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound 117
Tumor-Induced Myeloid-Derived Suppressor Cells 114
The dark side of tumor-associated endothelial cells 112
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 110
Tandem Dye-Doped Nanoparticles for NIR Imaging via Cerenkov Resonance Energy Transfer 110
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy 108
Optical emission of (223) Radium: in vitro and in vivo preclinical applications 101
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 100
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 97
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses 79
A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2- ORCHESTRA Project 68
How to Reprogram Myeloma-Associated Macrophages: Target {IKZF}1 65
Maternal Phylogenetic Relationships and Genetic Variation among Rare, Phenotypically Similar Donkey Breeds 60
IL-27: overclocking cytotoxic T lymphocytes to boost cancer immunotherapy 52
Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy 37
c-FLIP as a master regulator of immune homeostasis and disease mechanisms 26
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer 15
Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study 13
Muscle contribution in lipid nanoparticle mediated mRNA vaccine delivery and efficacy 8
Totale 9.674
Categoria #
all - tutte 34.459
article - articoli 33.515
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 944
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022194 0 0 0 21 10 5 14 29 19 8 19 69
2022/2023752 44 89 62 136 59 193 13 35 75 5 30 11
2023/2024585 20 35 44 54 65 117 51 32 4 46 89 28
2024/20251.732 79 59 83 243 61 86 208 155 238 86 153 281
2025/20264.383 280 226 279 700 1.120 276 404 234 375 295 88 106
2026/2027660 103 119 199 239 0 0 0 0 0 0 0 0
Totale 9.674